Randomized controlled trial of oral glutathione supplementation on body stores of glutathione
Tóm tắt
Tài liệu tham khảo
Meister A, Anderson ME (1983) Glutathione. Annu Rev Biochem 52:711–760
Jollow DJ (1980) Glutathione thresholds in reactive metabolite toxicity. Arch Toxicol Suppl 3:95–110
Kariya C, Leitner H, Min E, van Heeckeren C, van Heeckeren A, Day BJ (2007) A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration. Am J Physiol Lung Cell Mol Physiol 292:L1590–L1597. doi:10.1152/ajplung.00365.2006
Novi AM (1981) Regression of aflatoxin B1-induced hepatocellular carcinomas by reduced glutathione. Science 212:541–542
Morris D, Khurasany M, Nguyen T, Kim J, Guilford F, Mehta R, Gray D, Saviola B, Venketaraman V (2013) Glutathione and infection. Biochim Biophys Acta 1830:3329–3349. doi:10.1016/j.bbagen.2012.10.012
Nichenametla SN, Ellison I, Calcagnotto A, Lazarus P, Muscat JE, Richie JP Jr (2008) Functional significance of the GAG trinucleotide-repeat polymorphism in the gene for the catalytic subunit of gamma-glutamylcysteine ligase. Free Radic Biol Med 45:645–650. doi:10.1016/j.freeradbiomed.2008.05.012
Allen J, Bradley RD (2011) Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med 17:827–833. doi:10.1089/acm.2010.0716
Richie JP Jr, Kleinman W, Marina P, Abraham P, Wynder EL, Muscat JE (2008) Blood iron, glutathione, and micronutrient levels and the risk of oral cancer. Nutr Cancer 60:474–482. doi:10.1080/01635580801956477
Nichenametla SN, Lazarus P, Richie JP Jr (2011) A GAG trinucleotide-repeat polymorphism in the gene for glutathione biosynthetic enzyme, GCLC, affects gene expression through translation. Faseb J 25:2180–2187. doi:10.1096/fj.10-174011
Nichenametla SN, Muscat JE, Liao JG, Lazarus P, Richie JP Jr (2012) A functional trinucleotide repeat polymorphism in the 5′-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers. Mol Carcinog. doi:10.1002/mc.21923
Pastore A, Piemonte F (2012) S-Glutathionylation signaling in cell biology: progress and prospects. Eur J Pharm Sci Off J Eur Fed Pharm Sci 46:279–292. doi:10.1016/j.ejps.2012.03.010
Ilhan N, Kamanli A, Ozmerdivenli R (2004) Variable effects of exercise intensity on reduced glutathione, thiobarbituric acid reactive substance levels, and glucose concentration. Arch Med Res 35:294–300. doi:10.1016/j.arcmed.2004.03.006
Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, Hosking SL (2005) Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 46:877–883. doi:10.1167/iovs.04-0777
Erden-Inal M, Sunal E, Kanbak G (2002) Age-related changes in the glutathione redox system. Cell Biochem Funct 20:61–66. doi:10.1002/cbf.937
Morris D, Guerra C, Donohue C, Oh H, Khurasany M, Venketaraman V (2012) Unveiling the mechanisms for decreased glutathione in individuals with HIV infection. Clin Dev Immunol 2012:734125. doi:10.1155/2012/734125
Nguyen D, Hsu JW, Jahoor F, Sekhar RV (2014) Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients. J Clin Endocrinol Metab 99:169–177. doi:10.1210/jc.2013-2376
Borges-Santos MD, Moreto F, Pereira PC, Ming-Yu Y, Burini RC (2012) Plasma glutathione of HIV(+) patients responded positively and differently to dietary supplementation with cysteine or glutamine. Nutrition 28:753–756. doi:10.1016/j.nut.2011.10.014
Hummelen R, Hemsworth J, Reid G (2010) Micronutrients, N-acetyl cysteine, probiotics and prebiotics, a review of effectiveness in reducing HIV progression. Nutrients 2:626–651. doi:10.3390/nu2060626